Sfoglia per AUTORE
NADA E
Collezione ASL Torino 3

  

Items : 11

Hospitalisation for herpes zoster in people with and without diabetes: A 10-year-observational study. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2024 Apr;210:111603. doi: 10.1016/j.diabres.2024.111603. Epub 2024 Mar 8.

2024
ASL Torino 5
ASL Torino 3

Gnavi R; Costa G; Romeo F; Picariello R; Tartaglino B; Nada E; Giorda CB;

Hepatocellular carcinoma in a large cohort of type 2 diabetes patients. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2023 Jun;200:110684. doi: 10.1016/j.diabres.2023.110684. Epub 2023 Apr 24.

2023
ASL Torino 3
ASL Torino 5

Monge L; Gnavi R; Manti R; Nada E; Costa G; Tartaglino B; Giorda CB; Picariello R;

Instructive lessons from the analysis of assistance in diabetes during the first phase of COVID-19 pandemic. in Acta diabetologica / Acta Diabetol. 2022 Jun;59(6):861-864. doi: 10.1007/s00592-022-01855-6. Epub 2022 Feb 19.

2022
ASL Torino 4
ASL Torino 5
ASL Torino 3

Gnavi R; Romeo F; Doglio M; Nada E; Landriscina T; Giorda CB; Picariello R; Tartaglino B;

Hepatic fibrosis of any origin in a large population of type 2 diabetes patients. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2021 Sep 22;31(10):2887-2894. doi: 10.1016/j.numecd.2021.06.020. Epub 202

2021
ASL Torino 5
ASL Torino 3

Romeo F; Costa G; Giorda CB; Linzalata C; Nada E; Tartaglino B; Picariello R; Gnavi R;

From swab testing to health outcomes within the T2DM population: Impact of diabetes background on COVID19 progression. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2021 Oct;180:109021. doi: 10.1016/j.diabres.2021.109021. Epub 2021 Aug 23.

2021
ASL Torino 5
ASL Torino 3

Gnavi R; Romeo F; Costa G; Doglio M; Nada E; Tartaglino B; Picariello R; Giorda CB;

Incretin-based therapy and risk of cholangiocarcinoma: a nested case-control study in a population of subjects with type 2 diabetes. in Acta diabetologica / Acta Diabetol. 2020 Apr;57(4):401-408. doi: 10.1007/s00592-019-01444-0. Epub 2019 Nov 5.

2020
ASL Torino 5
ASL Torino 3

Nada E; Gnavi R; Costa G; Tartaglino B; Picariello R; Giorda CB;

Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies. in Endocrine / Endocrine. 2015 Mar;48(2):461-71. doi: 10.1007/s12020-014-0386-8. Epub 2014 Aug 22.

2015
ASL Torino 5
ASL Torino 3

Gnavi R; Baldi I; Marafetti L; Sacerdote C; Nada E; Giorda CB;

A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position. in Diabetes, obesity & metabolism / Diabetes Obes Metab. 2014 Nov;16(11):1041-7. doi: 10.1111/dom.12297. Epub 2014 Apr 29.

2014
ASL Torino 5
ASL Torino 3

Marafetti L; Tartaglino B; Nada E; Gnavi R; Giorda CB;

Comparison of direct costs of type 2 diabetes care: different care models with different outcomes. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2014 Jul;24(7):717-24. doi: 10.1016/j.numecd.2014.01.009. Epub 2014 Jan 2

2014
ASL Torino 5
ASL Torino 3

Costa G; Gnavi R; Petrelli A; Marafetti L; Picariello R; Tartaglino B; Nada E; Giorda CB;

Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study. in The lancet. Diabetes & endocrinology / Lancet Diabetes Endocrinol. 2014 Feb;2(2):111-5. doi: 10.1016/S2213-8587(13)70147-5. Epub 2013 Nov 1

2014
ASL Torino 5
ASL Torino 3

Gnavi R; Marafetti L; Costa G; Tartaglino B; Giorda CB; Nada E; Picariello R;

The impact of adherence to screening guidelines and of diabetes clinics referral on morbidity and mortality in diabetes. in PloS one / PLoS One. 2012;7(4):e33839. doi: 10.1371/journal.pone.0033839. Epub 2012 Apr 3.

2012
ASL Torino 5
ASL Torino 3

Gnavi R; Costa G; Marafetti L; Tartaglino B; Picariello R; Nada E; Giorda C;